InsidersTradesSigma
Track the Selectis Health, INC. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Operating in the Healthcare & Pharma sector, Selectis Health, INC. has recorded 8 public disclosures. Market capitalisation: €16.3m. The latest transaction was filed on 14 January 2026 (Acquisition). Among the most active insiders: Baller Lance. Every trade is free.
8
Insider Decl.
n/a
Thresholds
€126,137
6 ops.
Buy Volume
n/a
n/a
Sell Volume
46Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,739 of 29,064 companies
29.5
score / 100
Value41
Quality19
FCF yld8.7%
Earn yld-6.3%
EV/EBITDA19.2x
ROE·
Gross mgn23%
Net mgn-2.5%
Debt/EBITDA11.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 14 January 2026
Declarations8 total
6,192 shares@ US$2.208.1% of flowCommon StockSEC:0001493152-26-002308:0
Canonical exit: 18 Mar 2026 (T+90)
100 shares@ US$5.800.2% of flowCommon StockSEC:0001493152-22-027913:0
Canonical exit: 4 Jan 2023 (T+90)
20,000 shares@ US$5.000.81% mcap33.7% of flowCommon StockSEC:0001493152-22-001130:0
100,000 shares@ US$0.5029.9% of flowCommon StockSEC:0001493152-21-022334:0
100,000 shares@ US$0.500.39% mcap25.0% of flowCommon StockSEC:0001493152-21-018848:0
Canonical exit: 7 Oct 2021 (T+90)
100,000 shares@ US$0.50100.0% of flowCommon StockSEC:0001493152-21-016916:0
Canonical exit: 7 Oct 2021 (T+90)
50,000 shares@ US$0.50100.0% of flowCommon StockSEC:0001493152-21-016704:0
Canonical exit: 7 Oct 2021 (T+90)
20,000 shares@ US$0.50100.0% of flowCommon StockSEC:0001493152-21-016705:0
Canonical exit: 7 Oct 2021 (T+90)
8 of 8 declarations
关于 Selectis Health, INC.
Selectis Health, Inc.（股票代码：GBCS）是一家总部位于美国医疗保健公司，其股票在OTCQB市场报价。这种结构通常使其与投资者关注的NYSE/NASDAQ股票一起，被纳入小型美国股票的筛选范围。该公司在美国注册成立，并在科罗拉多州格林伍德村运营。其公司历史可追溯至Global Healthcare REIT, Inc.，更名为Selectis Health旨在更好地匹配其商业模式，该模式现在以拥有和运营医疗保健设施为中心，而非作为传统的REIT式空壳公司运营。([sec.gov](https://www.sec.gov/Archives/edgar/data/727346/000149315226016827/0001493152-26-016827-index-headers.html?utm_source=openai)) 从行业角度来看，Selectis Health定位于长期和急性后期护理领域的利基运营商。其业务包括拥有和/或运营服务于老年人和康复患者的医疗保健设施，服务范围涵盖专业护理、康复、辅助生活、言语治疗、职业治疗、物理治疗、社会服务以及更广泛的医疗保健支持功能。这使得该公司成为美国医疗保健市场中一个结构性吸引人但运营要求高的细分市场中的高度专业化参与者。需求受到人口老龄化的支持，但该行业也面临劳动力成本、人员配备可用性、报销压力以及州/联邦监管复杂性等重大风险。([sec.gov](https://www.sec.gov/Archives/edgar/data/727346/000149315223043689/ex99-1.htm?utm_source=openai)) 从地理上看，Selectis历来在阿肯色州、佐治亚州、俄亥俄州和俄克拉荷马州开展业务，管理层曾提及一项增长战略，重点是扩大其在美国中南部和东南部市场的业务范围。这种地理定位对投资者很重要，因为它表明这是一个区域集中的平台，而非全国性运营商。在竞争方面，Selectis在一个由区域运营商、私人所有者和大型公共同行组成的碎片化市场中竞争。其竞争优势不在于规模，而在于本地运营专业知识、资产层面管理以及通过积极的投资组合管理来改进或重新定位设施的能力。([sec.gov](https://www.sec.gov/Archives/edgar/data/727346/000149315223043689/ex99-1.htm?utm_source=openai)) 近期公司发展颇具看点。2024年，Selectis宣布Adam Desmond担任常任首席执行官，标志着领导层稳定。2025年，公司股票被升级至OTCQB，这通常会提高市场知名度和交易质量，相对于较低的OTC层级。公司还继续重塑其投资组合，包括出售某些佐治亚州设施，表明其采取了严谨的资产合理化方法。最近，在2026年3月，Black Pearl Equities发起了一项要约收购，以每股5.05美元现金的价格收购Selectis Health高达100%的股份，这对股东来说是一个重要的战略事件，突显了在此名称中，公司行动可能比传统的运营势头更重要。对于投资者而言，Selectis Health仍然是OTC市场上一家小型美国医疗保健运营商，具有明显的事件驱动型特征。([nasdaq.com](https://www.nasdaq.com/press-release/selectis-health-makes-key-leadership-announcement-2024-10-17?utm_source=openai))
